Fredun Pharmaceuticals Ltd Share Price ₹2,311

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Fredun Pharmaceuticals Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	80	62	82	87	118	79	107	103	167	120	145	161	213
Expenses +	68	54	72	76	107	68	93	89	150	103	123	135	184
Operating Profit	12	8	10	11	11	10	14	13	17	17	22	26	29
OPM %	15%	12%	12%	12%	9%	13%	13%	13%	10%	14%	15%	16%	14%
Other Income +	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	4	3	3	4	4	4	5	5	8	7	8	11	14
Depreciation	1	1	1	1	1	1	1	1	1	1	2	2	3
Profit before tax	8	4	6	6	6	6	8	7	8	9	13	14	12
Tax %	51%	41%	32%	27%	13%	25%	44%	25%	12%	25%	25%	25%	4%
Net Profit +	4	2	4	4	5	4	4	5	7	7	10	10	11
EPS in Rs	8.58	5.24	8.41	8.98	10.76	8.75	9.04	11.29	14.97	14.34	20.61	19.53	20.23

Financials of Fredun Pharmaceuticals Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	25	42	57	60	97	113	134	222	275	348	454	639
Expenses +	24	38	53	54	87	104	126	208	247	310	401	544
Operating Profit	2	4	3	6	10	8	8	14	28	38	53	95
OPM %	7%	9%	6%	10%	11%	7%	6%	6%	10%	11%	12%	15%
Other Income +	0	1	2	0	0	1	1	2	2	1	2	0
Interest	1	2	2	2	3	4	4	5	9	14	22	39
Depreciation	1	1	1	1	1	2	2	2	3	4	4	8
Profit before tax	1	2	2	3	6	2	3	9	18	21	28	48
Tax %	52%	42%	36%	34%	28%	24%	37%	26%	38%	27%	26%	30%
Net Profit +	0	1	1	2	4	2	2	6	11	16	21	33
EPS in Rs	1.11	4.55	6.08	5.11	11.18	4.76	5.04	14.30	23.85	33.22	44.07	60.68
Dividend Payout %	0%	13%	10%	12%	6%	14%	14%	5%	3%	2%	2%	0%

Financials of Fredun Pharmaceuticals Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	2	3	4	4	4	4	5	5	5	5
Reserves	0	1	2	19	35	37	39	64	92	117	137	273
Borrowings +	9	16	21	10	19	35	40	53	87	106	166	222
Other Liabilities +	11	24	30	47	47	65	79	66	74	81	179	141
Total Liabilities	23	43	56	79	105	141	162	187	257	308	487	642
Fixed Assets +	8	15	16	16	31	31	30	32	39	47	53	118
CWIP	1	0	4	11	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	1	2	2
Other Assets +	14	29	36	52	74	110	131	155	218	260	433	522
Total Assets	23	43	56	79	105	141	162	187	257	308	487	642

Financials of Fredun Pharmaceuticals Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	2	3	4	17	1	-11	0	-2	-14	-0	-29	120
Cash from Investing Activity +	-3	-6	-7	-8	-5	-1	-1	-4	-9	-8	-6	-74
Cash from Financing Activity +	1	3	3	-8	4	14	-1	7	25	6	38	18
Net Cash Flow	0	1	-1	1	0	2	-2	1	1	-2	3	65
Free Cash Flow	-1	-3	-3	9	-4	-12	-1	-7	-24	-8	-35	46
CFO/OP	108%	85%	117%	303%	8%	-128%	2%	-17%	-52%	-1%	-55%	126%

Financials of Fredun Pharmaceuticals Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	75	98	131	94	67	126	112	148	46	68	142	53
Inventory Days	102	140	68	170	249	227	242	96	264	246	267	217
Days Payable	167	221	224	360	205	208	215	101	104	88	161	70
Cash Conversion Cycle	11	17	-24	-96	110	145	139	144	205	225	248	199
Working Capital Days	-54	-44	-39	42	66	65	116	126	97	92	76	78
ROCE %	14%	25%	18%	16%	21%	10%	10%	13%	18%	17%	19%	21%